Mr. Sherman has served on the Board of Directors of Ekso Bionics since December 2013. Since 1988, Mr. Sherman has been a member of Sherman Capital Group, a Merchant Banking organization with a portfolio of private and public investments. In addition to Ekso Bionics, Mr. Sherman is currently Chairman of Purple Wave Inc. Mr. Sherman is a founder of Novatel Wireless, Inc., Vodavi Communications Systems Inc. and Main Street and Main Inc. Previously, Mr. Sherman has served as a director of Telit; Chairman of Airlink Communications, Inc. until its sale to Sierra Wireless, Inc.; Chairman of Executone Information Systems; and as a director of Inter-Tel (Delaware) Incorporated.
Charles Li, Ph.D.
Dr. Li has been a senior analyst at Puissance Capital Management since 2015 and has been involved in many of Puissance Capital's investments. Prior to joining Puissance Capital, Dr. Li worked at Fosun Capital and Harvest Fund. Dr. Li received his Ph.D. in Applied Physics from Harvard University, and a B.S. and B.A. from X'an Jiaotong University in Xi'an, China.
President, Chief Executive Officer and Director
Mr. Peurach has served on the Board of Directors of Ekso Bionics since January 2012. Since 2011, Mr. Peurach has been the Executive Vice President, Products for SunPower Corp (NASDAQ: SPWR), where he is responsible for all aspects of SunPower’s PV modules and residential, commercial and utility PV systems. Prior to this role, from 2009 to 2011, Mr. Peurach served as Executive Vice President, Research and Development for SunPower, where he led the research and development efforts of the PV Cells, Modules and Systems. From 2008 to 2009, Mr. Peurach was the Vice President of the Advanced Product Development Group, and from 2007 to 2008, Mr. Peurach was the Senior Director of Product Development at SunPower. Prior to SunPower’s acquisition of PowerLight in 2007, Mr. Peurach served as PowerLight’s Vice President of Product Development. Earlier in his career, Mr. Peurach was a strategy consultant for Mercer Management Consulting and director of engineering at Berkeley Process Control, Inc. He holds a Bachelor of Science degree in mechanical engineering from Michigan State University, a Master of Science degree in mechanical engineering from the University of California, Berkeley, and a Master of Business administration, finance and entrepreneurship from the Wharton School, University of Pennsylvania.
Mr. Stern currently is Managing Partner of Alnitak Capital, which he founded in 2013 to provide Board level strategic advisory services, primarily in technology related industries. Before founding Alnitak, Mr. Stern was a Managing Director at Oppenheimer & Co. from 1995-2000 and from 2004 to 2013, where, among other positions, he led the firm's investment banking department and technology investment banking groups. Prior to joining Oppenheimer & Co, Mr. Stern held roles at Salomon Brothers, STI Ventures and C.E. Unterberg.
Mr. Stern is currently the Chairman of the Board of Audiocodes Inc., a leader in VOIP infrastructure equipment, and a member of the Board and Chairman of the Audit Committee of Foamix, Inc. Previously Mr. Stern was a member of the Board of Directors, member of the Audit Committee at Given Imaging and a Member of the Board of Directors, and Chairman of Audit Committee at Fundtech Inc., and Chairman of the Board of Tucows, Inc. Mr. Stern holds a B.A. in Economics and Accounting from City University of New York, Queens College, and an M.B.A. from Harvard University.
Mary Ann Cloyd
Ms. Cloyd brings nearly 40 years of experience in public accounting and advisory, corporate governance, and risk management and oversight. She currently serves on the Boards of Bellerophon Therapeutics, Fresh Del Monte Produce, and NCMIC Group. Active in professional and community organizations, Ms. Cloyd is also on the Board of the Geffen Playhouse and the Advisory Board of the UCLA Iris Cantor Women’s Center. From 1990 until her retirement in 2015, Ms. Cloyd was a senior partner at PricewaterhouseCoopers LLP (“PwC”), where she served multinational corporate clients in a variety of industries, including the biotechnology and pharmaceutical industries. She was the leader of the PwC Center for Board Governance from 2012 to 2015 and has also served on both PwC’s Global and U.S. Boards. Ms. Cloyd also served on the Board of Trustees of the PwC Charitable Foundation, and previously served as President of the Foundation.
Rhonda A. Wallen
Ms. Wallen has 25 years of experience working within the life sciences and healthcare industries. With a focus on business management and corporate development, Ms. Wallen brings board oversight as well as investment expertise. Currently VP Marketing & Corporate Development of SteriLumen, the medical division of AppliedUV, she was most recently the Head of Corporate Development for Terumo BCT, the biomedical division of Terumo Corporation. Previously, Ms. Wallen served as the Chief Operating Officer of Andarix Pharmaceuticals. Also, during this time as a consultant with Cygnet Venture Management, she held senior level business development and marketing positions where she worked with life science CEOs and founders to validate the strategic direction of emerging growth companies, define key milestones and complete corporate financings. Ms. Wallen is a Director of Boulder Community Health, and a Board Advisor to venture-backed companies, DrugViu and Aromyx.